【発明の名称】HMGCoAレダクターゼ阻害剤を用いるアルツハイマー病の治療、予防および発症リスクの低下法

Title:

【発明の名称】HMGCoAレダクターゼ阻害剤を用いるアルツハイマー病の治療、予防および発症リスクの低下法

Document Type and Number:

Japanese Patent JP2002529500

Kind Code:

A

Abstract:

Described are methods for treating, preventing, or reducing the risk of the onset of Alzheimer's disease by administering a therapeutically effective amount of an inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A reductase ("HMG CoA reductase inhibitor") to a patient who is at risk for a coronary or cerebrovascular event or at risk for Alzheimer's disease.

More Like This:

JP4831715	Monomer manufacturing method
JPH03246290	PRODUCTION OF PYRANE DERIVATIVE
JPS6013012	[Title of the Invention] A manufacturing process of the ester using a homogeneous catalyst

Inventors:

Orojin Benjamin

Application Number:

JP2000582029A

Publication Date:

September 10, 2002

Filing Date:

November 15, 1999

Export Citation:

Click for automatic bibliography generation Help

Assignee:

NYMOX CORPORATION

International Classes:

C07D309/30; A61K31/00; A61K31/22; A61K31/366; A61K31/40; A61K31/403; A61K31/404; A61K31/405; A61K31/4418; A61K45/00; A61P3/06; A61P3/10; A61P9/08; A61P9/10; A61P9/12; A61P25/28; A61P25/34; C07D207/34; C07D209/24; (IPC1-7): A61K45/00; A61K31/22; A61K31/366; A61K31/40; A61K31/405; A61P3/06; A61P3/10; A61P9/08; A61P9/10; A61P9/12; A61P25/28; A61P25/34; C07D207/34

Foreign References:

WO1995006470A1	1995-03-09
EP0179559A2	1986-04-30

Attorney, Agent or Firm:

Shimizu Hatsushi (1 person outside)

Previous Patent: 痛みの治療方法

Next Patent: 新規４−デジメチルアミノテトラサイクリン誘導体